Rete Biomedical Communications is categorized under Publishing Consultants in Wyckoff, NJ .
Rete Biomedical Communications was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Publishing Consultants business, which does work in the B2B market, and is classified as a Publishing Consultants, under code number 5416110 by the NAICS.
If you are seeking more information, feel free to contact Julie Collins, Partner at the company’s single location by writing to 191 Godwin Avenue # 1, Wyckoff, New Jersey NJ 07481 or by phoning (201) 891-8205. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Rete Biomedical Communications |
Contact Person: | Julie Collins, Partner |
Address: | 191 Godwin Avenue # 1, Wyckoff, New Jersey 07481 |
Phone Number: | (201) 891-8205 |
Website Address: | retebiomed.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Publishing Consultants |
SIC Code: | 8742 |
NAICS Code: | 5416110 |
Share This Business: |
Rete Biomedical Communications was started in 0 to provide professional Publishing Consultants under the SIC code 8742 and NAICS code 5416110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Julie Collins, Partner for inquiries that concern Rete Biomedical Communications by calling the company number (201) 891-8205, as your correspondence is most welcome. Additionally, the physical location of the single location of Rete Biomedical Communications can be found at the coordinates 41.00595,-74.15969 as well as the street address 191 Godwin Avenue # 1 in Wyckoff, New Jersey 07481.
For its online presence, you may visit Rete Biomedical Communications’s website at retebiomed.com and engage with its social media outlets through on Twitter and on Facebook.